Benjamin Kaffenberger, MD

Videos

Dermatological experts discuss challenges that are associated with the use of standard and emerging treatments in special patient population.

Patient Subgroups and Educational Opportunities in Rare Dermatological Disorders

Experts discuss how to improve recognition and referral for rare dermatologic conditions in the ER setting.

Improving Recognition and Referral of Rare Conditions in Rare Setting

Boni Elewski, MD, and Benjamin Kaffenberger, MD, and Carly Elston, MD, provide their clinical recommendations regarding future treatments for rare dermatological disorders. 

Future Treatment Outlook for Rare Dermatological Disorders

Experts discuss spesolimab, an IL-36 inhibitor, that was recently FDA approved for treatment of GPP.

Benjamin Kaffenberger, MD

Articles